Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 103 of the 105 references it cites were found in a registry or an index.

Standardisation framework for the Maudsley staging method for treatment resistance in depression

Open access

Abstract

BACKGROUND: Treatment-resistant depression (TRD) is a serious and relatively common clinical condition. Lack of consensus on defining and staging TRD remains one of the main barriers to understanding TRD and approaches to intervention. The Maudsley Staging Method (MSM) is the first multidimensional model developed to define and stage treatment-resistance in "unipolar depression". The model is being used increasingly in treatment and epidemiological studies of TRD and has the potential to support consensus. Yet, standardised methods for rating the MSM have not been described adequately. The aim of this report is to present standardised approaches for rating or completing the MSM. METHOD: Based on the initial development of the MSM and a narrative review of the literature, the developers of the MSM provide explicit guidance on how the three dimensions of the MSM--treatment failure, severity of depressive episode and duration of depressive episode-- may be rated. RESULT: The core dimension of the MSM, treatment failure, may be assessed using the Maudsley Treatment Inventory (MTI), a new method developed for the purposes of completing the MSM. The MTI consists of a relatively comprehensive list of medications with options for rating doses and provisions treatment for multiple episodes. The second dimension, severity of symptoms, may be assessed using simple instruments such as the Clinical Global Impression, the Psychiatric Status Rating or checklist from a standard diagnostic checklist. The standardisation also provides a simple rating scale for scoring the third dimension, duration of depressive episode. CONCLUSION: The approaches provided should have clinical and research utility in staging TRD. However, in proposing this model, we are fully cognisant that until the pathophysiology of depression is better understood, staging methods can only be tentative approximations. Future developments should attempt to incorporate other biological/ pathophysiological dimensions for staging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12888-018-1679-x

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Current linear staging models (first figure) compare with the Maudsley staging method (last figure) and a more ideal interactive aetiological model (middle figure)
Fig. 1 Current linear staging models (first figure) compare with the Maudsley staging method (last figure) and a more ideal interactive aetiological model (middle figure)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 105 references

Research works printed but not linked: 6

  1. Helmchen H. Therapy-resistant depression: symptoms and syndromes. Contributions to symptomatology and syndromes. Pharmakopsychiatr Neuropsychopharmakol. 1974;7(3):139–44. · DOI
  2. National Institute for Health and Clinical Excellence: Clinical guideline 23 (amended) depression: management of depression in primary and secondary care. In.: National Institute for Health and Clinical Excellence; 2007: 34.
  3. Charney DS, Miller HL, Licinio J, Salomon R. Treatment of depression. In: Schatzberg AF, Nemeroff CB, editors. The American textbook of psychopharmacology. Washington, DC: American Psychiatric Press, Inc; 2005. p. 588.
  4. Centers for Medicare and Medicaid Services: Medicare Evidence Development & Coverage Advisory Committee: Panel Proceedings. In: 2016; Baltimore, Maryland: Centers for Medicare and Medicaid Services; 2016.
  5. World Health Organisation. The ICD-10 classification of mental and Behavioural disorders clinical descriptions and diagnostic guidelines 10th edn. Geneva: WHO; 1992.
  6. Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in psychiatry 12th edn. London: Wiley-Blackwell; 2015.

Cited by

See all 119

Metadata

Authors
Fekadu, A., Donocik, J. G., & Cleare, A. J.
Affiliations
  • Brighton and Sussex Medical School (GB)
  • King's College London (GB)
Corresponding author
Fekadu, Abebaw
Venue
BMC Psychiatry
Published
2018-04-11
Volume
18
Issue
1
Pages
100-100
ISSN
1471-244X (ISSN-L)
OpenAlex
W2796957480
Cited by
106
References
105
Citations by year
2026: 19 · 2025: 16 · 2024: 9 · 2023: 17 · 2022: 10 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 2
FWCI
5.65
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
Funders
No funding source for this work
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
treatment-resistant depression, treatment failure, depressive episode severity, depressive episode duration, major depressive disorder, rating scales
MeSH terms
Humans, Models, Psychological, Psychiatric Status Rating Scales, Practice Guidelines as Topic, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standardisation framework for the Maudsley staging method for treatment resistance in depression. https://app.cochat.ai/papers/10.1186/s12888-018-1679-x
The paper
Fekadu, A., Donocik, J. G., & Cleare, A. J. (2018). Standardisation framework for the Maudsley staging method for treatment resistance in depression. BMC Psychiatry. https://doi.org/10.1186/s12888-018-1679-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.